Table 2. Comparisons of patient co-morbidities between AMA and non-AMA groups.
Patient co-morbidities | AMA(n = 328) | Non-AMA(n = 328) | p-value |
Neurologic Conditions | 71 (22%) | 22 (7%) | <0.001 |
Alcoholism | 93 (28%) | 42 (13%) | <0.001 |
Gastrointestinal bleeding | 45 (14%) | 11 (3%) | <0.001 |
Psychiatric illness | 86 (26%) | 46 (14%) | <0.001 |
Soft-tissue infections | 155 (47%) | 75 (23%) | <0.001 |
HCV | 201 (61%) | 122 (37%) | <0.001 |
HIV | 111 (34%) | 96 (29%) | 0.07 |
Diabetes | 19 (6%) | 32 (10%) | 0.07 |
COPD | 44 (13%) | 38 (12%) | 0.46 |
CHF | 10 (3%) | 11 (3%) | 1 |
Injection Drug Use | 178 (54%) | 76 (23%) | <0.001 |
Number of co-morbidities (median, IQR) | 4 (3, 5) | 2 (1, 3) | <0.001 |
0–1 | 31 (9.5%) | 134 (40.9%) | |
2–3 | 73 (22.3%) | 117 (35.7%) | |
≥4 | 224 (68.3%) | 77 (23.5%) |
HCV = hepatitis C virus; COPD = chronic obstructive pulmonary disease; CHF = congestive heart failure.